The tumor immune microenvironment shapes response to pembrolizumab in microsatellite instability-high endometrial cancer

被引:0
|
作者
How, Jeffrey [1 ]
Dang, Minghao [1 ]
Euscher, Elizabeth [1 ]
Yates, Melinda [1 ]
Peng, Weiyi [2 ]
Patel, Shrina [1 ]
Lu, Karen [1 ]
Hwu, Patrick [1 ]
Naing, Aung [1 ]
Wang, Linghua [1 ]
Jazaeri, Amir [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Houston, Houston, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
584
引用
收藏
页码:S308 / S308
页数:1
相关论文
共 50 条
  • [1] The impact of the tumor immune microenvironment on response to pembrolizumab in patients with microsatellite instability-high endometrial cancer.
    How, Jeffrey A.
    Dao, Minghao
    Euscher, Elizabeth
    Yates, Melinda
    Peng, Weiyi
    Patel, Shrina D.
    Lu, Karen H.
    Hwu, Patrick
    Wang, Linghua
    Jazaeri, Amir A.
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [2] Predictors of innate resistance to pembrolizumab in patients with microsatellite instability-high endometrial cancer
    How, Jeffrey A.
    Dang, Minghao
    Ferri-Borgogno, Sammy
    Euscher, Elizabeth
    Yates, Melinda S.
    Peng, Weiyi
    Patel, Shrina D.
    Burks, Jared J.
    Vletic, Ivo
    Gomez, Javier
    Lu, Karen
    Mok, Samuel C.
    Wang, Linghua
    Jazaeri, Amir A.
    CANCER RESEARCH, 2022, 82 (12)
  • [3] A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer
    Noguchi, Daito
    Seki, Toshiyuki
    Kubonoya, Yutaro
    Komazaki, Hiromi
    Ozone, Hirokazu
    Yanaihara, Nozomu
    Takano, Hirokuni
    Okamoto, Aikou
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 38
  • [4] Durable response to pembrolizumab in microsatellite instability-high advanced adrenocortical carcinoma
    Senda, Masaya
    Hashimoto, Kohei
    Shindo, Tetsuya
    Kobayashi, Ko
    Tanaka, Toshiaki
    Masumori, Naoya
    IJU CASE REPORTS, 2023, 6 (06) : 382 - 385
  • [5] Comparative analysis of the tumor immune microenvironment (TIME) in primary and metastatic sites of microsatellite stable (MSS) and microsatellite instability-high (MSI) colorectal cancer
    Fakih, M.
    Ye, J.
    Wang, C.
    Egelston, C.
    Huang, M.
    Mercer, J.
    Thompson, M. A.
    Gong, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S422 - S422
  • [6] Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
    O'Malley, David M.
    Bariani, Giovanni Mendonca
    Cassier, Philippe A.
    Marabelle, Aurelien
    Hansen, Aaron R.
    Acosta, Ana De Jesus
    Miller, Wilson H., Jr.
    Safra, Tamar
    Italiano, Antoine
    Mileshkin, Linda
    Xu, Lei
    Jin, Fan
    Norwood, Kevin
    Maio, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (07) : 752 - 761
  • [7] Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High
    Kawai, Koji
    Tawada, Akinobu
    Onozawa, Mizuki
    Inoue, Takamitsu
    Sakurai, Hiromichi
    Mori, Ichiro
    Takiguchi, Yuichi
    Miyazaki, Jun
    ONCOTARGETS AND THERAPY, 2021, 14 : 4853 - 4858
  • [8] Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
    Hidaka, Yoshifumi
    Arigami, Takaaki
    Osako, Yusaku
    Desaki, Ryosuke
    Hamanoue, Masahiro
    Takao, Sonshin
    Kirishima, Mari
    Ohtsuka, Takao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [9] Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
    Yoshifumi Hidaka
    Takaaki Arigami
    Yusaku Osako
    Ryosuke Desaki
    Masahiro Hamanoue
    Sonshin Takao
    Mari Kirishima
    Takao Ohtsuka
    World Journal of Surgical Oncology, 20
  • [10] The difference of immune microenvironment betweende novometastatic and non-metastatic microsatellite instability-high colorectal cancer
    Chen, Kuo-Hsing
    Hs, Chia-Lang U.
    Su, Yu-Li
    Yuan, Chang-Tsu
    Tsai, Jia-Huei
    Liang, Yi-Hsin
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    CANCER RESEARCH, 2024, 84 (06)